Biotage AB (BIOT) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.011x

Based on the latest financial reports, Biotage AB (BIOT) has a cash flow conversion efficiency ratio of 0.011x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr43.00 Million ≈ $4.63 Million USD) by net assets (Skr3.85 Billion ≈ $413.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biotage AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotage AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BIOT total debt and obligations for a breakdown of total debt and financial obligations.

Biotage AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotage AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Treehouse Foods Inc
NYSE:THS
0.030x
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
0.028x
INKON Life Technology Co Ltd
SHE:300143
0.028x
Under Armour Inc C
NYSE:UA
0.194x
Henan Yicheng New Energy Co Ltd
SHE:300080
-0.017x
GMP Property SOCIMI SA
MC:YGMP
0.013x
Tourmaline Bio Inc.
NASDAQ:TRML
-0.078x
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
0.020x

Annual Cash Flow Conversion Efficiency for Biotage AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotage AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BIOT company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr4.11 Billion
≈ $442.62 Million
Skr413.00 Million
≈ $44.45 Million
0.100x +29.30%
2023-12-31 Skr3.66 Billion
≈ $393.55 Million
Skr284.00 Million
≈ $30.56 Million
0.078x -62.72%
2022-12-31 Skr1.64 Billion
≈ $176.17 Million
Skr341.00 Million
≈ $36.70 Million
0.208x -19.04%
2021-12-31 Skr1.37 Billion
≈ $147.65 Million
Skr353.00 Million
≈ $37.99 Million
0.257x -8.72%
2020-12-31 Skr990.04 Million
≈ $106.54 Million
Skr279.05 Million
≈ $30.03 Million
0.282x +16.50%
2019-12-31 Skr875.50 Million
≈ $94.22 Million
Skr211.81 Million
≈ $22.79 Million
0.242x +9.59%
2018-12-31 Skr702.18 Million
≈ $75.57 Million
Skr155.00 Million
≈ $16.68 Million
0.221x -20.47%
2017-12-31 Skr608.61 Million
≈ $65.50 Million
Skr168.93 Million
≈ $18.18 Million
0.278x +12.42%
2016-12-31 Skr563.24 Million
≈ $60.61 Million
Skr139.07 Million
≈ $14.97 Million
0.247x +12.41%
2015-12-31 Skr546.66 Million
≈ $58.83 Million
Skr120.08 Million
≈ $12.92 Million
0.220x +36.47%
2014-12-31 Skr502.65 Million
≈ $54.09 Million
Skr80.91 Million
≈ $8.71 Million
0.161x +35.21%
2013-12-31 Skr476.77 Million
≈ $51.31 Million
Skr56.76 Million
≈ $6.11 Million
0.119x -15.15%
2012-12-31 Skr530.83 Million
≈ $57.13 Million
Skr74.47 Million
≈ $8.01 Million
0.140x -27.45%
2011-12-31 Skr563.90 Million
≈ $60.68 Million
Skr109.05 Million
≈ $11.74 Million
0.193x +90.70%
2010-12-31 Skr567.95 Million
≈ $61.12 Million
Skr57.59 Million
≈ $6.20 Million
0.101x +204.67%
2009-12-31 Skr1.09 Billion
≈ $117.20 Million
Skr36.25 Million
≈ $3.90 Million
0.033x -57.81%
2008-12-31 Skr1.12 Billion
≈ $121.05 Million
Skr88.74 Million
≈ $9.55 Million
0.079x +86.31%
2007-12-31 Skr796.26 Million
≈ $85.69 Million
Skr33.72 Million
≈ $3.63 Million
0.042x -24.40%
2006-12-31 Skr712.47 Million
≈ $76.67 Million
Skr39.91 Million
≈ $4.29 Million
0.056x +303.79%
2005-12-31 Skr738.25 Million
≈ $79.45 Million
Skr-20.29 Million
≈ $-2.18 Million
-0.027x +85.31%
2004-12-31 Skr523.13 Million
≈ $56.30 Million
Skr-97.89 Million
≈ $-10.53 Million
-0.187x -13.75%
2003-12-31 Skr609.50 Million
≈ $65.59 Million
Skr-100.27 Million
≈ $-10.79 Million
-0.165x +20.20%
2002-12-31 Skr616.16 Million
≈ $66.31 Million
Skr-127.02 Million
≈ $-13.67 Million
-0.206x --

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies
Market Cap
$1.23 Billion
Skr11.46 Billion SEK
Market Cap Rank
#8220 Global
#126 in Sweden
Share Price
Skr143.20
Change (1 day)
+0.14%
52-Week Range
Skr141.00 - Skr143.40
All Time High
Skr280.87
About

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more